Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma

Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma: a Retrospective Cohort Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06671431

Enrollment

578

Registered

2024-11-04

Start date

2000-01-01

Completion date

2024-10-01

Last updated

2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adjuvant Chemotherapy, Distal Cholangiocarcinoma

Brief summary

Recent studies addressing the role of adjuvant chemotherapy in cholangiocarcinoma (CCA) have been published; however, there are challenges in generalizing the findings due to different prognostic characteristics depending on tumor location and resectability. Therefore, the aim of this study was to investigate the role of AC in distal cholangiocarcinoma, a common tumor subtype of CCA.

Interventions

DRUGAdjuvant chemotherapy

Adjuvant chemotherapy with or without radiotherapy

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

19 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Patients with distal cholangiocarcinoma who underwent surgery

Exclusion criteria

* Who underwent neoadjuvant treatment * Who underwent R2 resection * Non-adenocarcinoma patients in final pathology report * Insufficient data * Death within 90days of surgery

Design outcomes

Primary

Measure	Time frame
Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma	From January 2000 to December 2021

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026